July 27, 2021 10:39 pm
The trials would cover 920 children, 460 each in the age-group of 12-17 and 2-11 across 10 sites.
August 25, 2021 11:28 pm
Covovax, manufactured by Serum Institute of India, will undergo a Phase II/III trial to measure safety and immune response across 20 hospital sites. Of those, eight sites are in Maharashtra.
June 26, 2021 7:57 am
Covovax is the second Covid-19 vaccine candidate, which is being developed and manufactured at Pune-based SII.
June 18, 2021 11:30 am
The recombinant nanoparticle protein-based vaccine — NVX-CoV2373 — developed by the American biotechnology firm has been branded Covovax in India.
June 06, 2021 8:08 am
Under a placebo-controlled trial, some volunteers are administered the drug while some are given a placebo to help researchers compare and understand the efficacy of the medication.
May 04, 2021 7:15 am
The Data Safety Monitoring Board has reviewed the initial safety data of 200 participants of phase-2 clinical trial of Covovax and has given its recommendation. The Drugs Controller General of India has given the go-ahead for a larger phase-3 trial.
April 30, 2021 8:35 am
The CEO of Serum Institute of India has urged President Joe Biden to lift the US embargo on export of vaccine raw materials. How important are these raw materials to vaccine manufacturers in India and other countries?